FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to pediatric otorhinolaryngology, allergology, clinical pharmacology, and is intended for pediatricians, otorhinolaryngologists, allergists, clinical pharmacologists, family physicians for the prevention and treatment of allergic rhinitis in the pre- and postoperative period in children with pharyngeal hypertrophy tonsils. In children aged 3 to 5 years with hypertrophy of the pharyngeal tonsil, who are indicated for endoscopic adenotomy, a complete blood count is performed; after which the allergization index (AI) is calculated according to the formula. With IA values less than 2.18, prevention and treatment of allergic rhinitis is not required before and after endoscopic adenotomy. At IA values of 2.18 and above, an allergen is searched for, followed by its elimination for three months before and after endoscopic adenotomy with systemic use of the leukotriene receptor blocker - Montelukast once at night 4 mg per day for 1 month after endoscopic adenotomy.
EFFECT: invention provides a simple, effective, inexpensive diagnostic criterion and recommendations for the prevention and treatment of allergic rhinitis before and after endoscopic adenotomy in children.
1 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING ALLERGIC RHINITIS IN THE POSTOPERATIVE PERIOD OF ENDOSCOPIC ADENOTOMY IN CHILDREN WITH HYPERTROPHY OF THE PHARYNGEAL TONSIL | 2022 |
|
RU2784292C1 |
METHOD FOR EARLY DIAGNOSIS OF ALLERGIC RHINITIS IN CHILDREN WITH DIFFICULTY IN NASAL BREATHING WITH HYPERTROPHY OF THE PHARYNGEAL TONSIL IN AN OUTPATIENT SETTING | 2022 |
|
RU2786478C1 |
COMBINED METHOD FOR TREATING UPPER SCHOOL PUPILS FOR CHRONIC ADENOIDITIS | 2005 |
|
RU2307686C1 |
METHOD FOR PREDICTING NATURE OF DEVELOPMENT AND TREATMENT OF CHRONIC EXUDATIVE OTITIS MEDIA IN CHILDREN | 2021 |
|
RU2758568C1 |
METHOD FOR TREATING CHRONIC ADENOIDITIS IN CHILDREN | 2002 |
|
RU2294758C2 |
SURGICAL METHOD FOR TREATING ADENOIDS | 2002 |
|
RU2212197C1 |
METHOD FOR NASAL MUCOUS MEMBRANES INNATE IMMUNITY DIAGNOSTICS TO JUSTIFY SELECTION OF TREATMENT FOR CHILDREN WITH ADENOID VEGETATION HYPERTROPHY | 2016 |
|
RU2623121C1 |
METHOD FOR INTEGRATED ASSESSMENT OF PREDICTED CLINICAL COURSE AND EFFECTIVENESS IN HYPERTROPHY OF PHARYNGEAL TONSIL AND CHRONIC ADENOIDITIS IN CHILDREN SHOWN BY SKIN OXIDANT/ANTIOXIDANT ACTIVITY | 2014 |
|
RU2565838C1 |
METHOD OF EVALUATING THE EFFECTIVENESS OF TREATMENT OF ADENOIDITIS IN PEDIATRIC PATIENTS | 2022 |
|
RU2804728C1 |
METHOD OF TREATING CHILDREN WITH DEGREE 1 AND 2 PHARYNGEAL TONSIL HYPERTROPHY | 2023 |
|
RU2822413C1 |
Authors
Dates
2022-11-23—Published
2022-05-05—Filed